The relationship between posttreatment 18F-fluorodeoxyglucose PET/computed tomography restaging and metabolic parameters with the prognosis of uterine cervical cancer
18 F-FDG PET/CT restaging, serum SCC-Ag, wbMTV, and wbTLG are established as prognostic biomarkers in recurrent cervical cancer. Posttreatment PET/CT represents a sensitive and accurate imaging technique for predicting patient outcomes.
Authors
- Yu Hua (ORCID: https://orcid.org/0000-0001-6857-1668)
- Qian Su (ORCID: https://orcid.org/0000-0003-4351-2631)
- Bin Wang (ORCID: https://orcid.org/0000-0001-7419-5080)
Institutions
- Tianjin Medical University Cancer Institute and Hospital (CN)
- Chinese PLA General Hospital (CN)
- National Clinical Research (US)
Publication Details
- Journal
- Nuclear Medicine Communications
- Published
- 2025-12-09
- DOI
- https://doi.org/10.1097/mnm.0000000000002093
- Primary Topic
- Endometrial and Cervical Cancer Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00